Company describes transaction as an exercise in disciplined portfolio management
Specialty
RTI Surgical® Tissue Matrix Line Extensions for International Markets
RTI will now offer a more pliable version of its Fortiva Tissue Matrix
U.S. FDA Clearance For UOC’s Polyethylene Knee Insert
Knee insert is designed to provide patients with knee replacements with reduced risk of oxidation
FDA Clears Mazor Robotics Spinal Deformity Correction Planning Software
Planning software is designed to work with the Mazor X Surgical Assurance Platform
SI-Joint Fusion in News as Si-Bone and Zyga Vie for Clinical Top Spot
It’s “C’mon Back and do the Sacroiliac” as SI-joint fusion has become one of MedTech’s hot topics
REFLECT Study Investigates Whether TriGuard™ Reduces Stroke Risk During TAVR
Pivotal international study aims to support FDA approval of cerebral protection device
Launch of MicroPort Orthopedics’ EVOLUTION® Revision Tibial System
Joint replacement specialist, MicroPort Orthopedics Inc., has announced the launch of the EVOLUTION® Revision Tibial System and EVOLUTION® BioFoam® Tibia
Boston Scientific to Acquire Symetis
Company says acquisition demonstrates continued commitment to structural heart portfolio
CE Mark for REVA’s Fantom Drug-Eluting Bioresorbable Stent
European launch of Fantom coronary stent underway
Rotation Medical Boss Appointed to Advamed Board
U. S MedTech trade association benefits from experience of one of the industry’s few women CEOs
US Momentum Drives SpineGuard to 23% Revenue Growth in Q1
It seems that making spine surgery safer is quite a lucrative business
Back to the Future as UK Medical Buys Out From BD
After selling to CareFusion in 2012, and then seeing that company acquired by BD, UK Medical will now return to ploughing its own furrow
Coronary Atherectomy Trial Sees First Patient
Cardiovascular Systems enrolls first subject in ECLIPSE coronary clinical trial
FDA Clearance for “Procedure in a Box” Uni Knee System
Bodycad receives FDA 510K clearance for personalized unicompartmental knee system
FDA Approves Medtronic CoreValve™ Evolut™ Pro Transcatheter Valve
First-ever data at ACC.17 confirms safety and efficacy of new self-expanding, recapturable heart valve at 30-days with high survival, low stroke and minimal paravalvular leak
MitraClip® Benefits People with Mitral Regurgitation
Study “validates that treatment with MitraClip can provide meaningful reduction in the severity of mitral regurgitation”